MASIMO CORPMASIEarnings & Financial Report
Masimo Corporation is an American health technology and consumer electronics company headquartered in Irvine, California. The company develops patient monitoring devices, non-invasive sensors, and related software platforms used in hospital and home settings. Masimo has also operated in the consumer audio and wearable device markets.
Revenue
$372.0M
Gross Profit
$234.0M
Operating Profit
$78.0M
Net Profit
$-170.7M
Gross Margin
62.9%
Operating Margin
21.0%
Net Margin
-45.9%
YoY Growth
-24.5%
EPS
$-3.12
MASIMO CORP Q1 FY2025 Financial Summary
MASIMO CORP reported revenue of $372.0M (down 24.5% YoY) for Q1 FY2025, with a net profit of $-170.7M (down 1003.2% YoY) (-45.9% margin). Cost of goods sold was $138.0M, operating expenses totaled $156.0M.
Key Financial Metrics
| Total Revenue | $372.0M |
|---|---|
| Net Profit | $-170.7M |
| Gross Margin | 62.9% |
| Operating Margin | 21.0% |
| Report Period | Q1 FY2025 |
MASIMO CORP Annual Revenue by Year
MASIMO CORP annual revenue history includes year-by-year totals (for example, 2024 revenue was $2.1B).
| Year | Annual Revenue |
|---|---|
| 2024 | $2.1B |
| 2023 | $2.0B |
| 2022 | $2.0B |
| 2021 | $1.2B |
MASIMO CORP Quarterly Revenue & Net Profit History
MASIMO CORP results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $371.5M | -26.4% | $-100.4M | -27.0% |
| Q2 FY2025 | $370.9M | -25.3% | $51.3M | 13.8% |
| Q1 FY2025 | $372.0M | -24.5% | $-170.7M | -45.9% |
| Q4 FY2024 | $600.7M | +9.4% | $-349.6M | -58.2% |
| Q3 FY2024 | $504.6M | +5.4% | $9.8M | 1.9% |
| Q2 FY2024 | $496.3M | +9.0% | $16.0M | 3.2% |
| Q1 FY2024 | $492.8M | -12.8% | $18.9M | 3.8% |
| Q4 FY2023 | $548.9M | -11.0% | $33.9M | 6.2% |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $548.9M | $492.8M | $496.3M | $504.6M | $600.7M | $372.0M | $370.9M | $371.5M |
| YoY Growth | -11.0% | -12.8% | 9.0% | 5.4% | 9.4% | -24.5% | -25.3% | -26.4% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $3.04B | $2.96B | $2.89B | $3.09B | $2.63B | $2.29B | $2.40B | $1.82B |
| Liabilities | $1.68B | $1.59B | $1.53B | $1.62B | $1.57B | $1.35B | $1.36B | $1.01B |
| Equity | $1.36B | $1.37B | $1.37B | $1.46B | $1.05B | $946.4M | $1.04B | $810.0M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $77.1M | $45.8M | $74.5M | $25.6M | $50.5M | $31.1M | $69.4M | $56.8M |